3B Pharmaceuticals is offering comprehensive peptide discovery and development projects for the development of therapeutic and diagnostic product candidates. With outstanding capabilities in medicinal chemistry, leads generated by various biological and chemical screening techniques are optimized to meet the desired target product profile. 3BP is managing preclinical discovery and development projects in close cooperation with its customers.

Areas of expertise include:

  • The identification of novel active peptides using powerful biological display technologies with industry-leading diversity and through focused chemical libraries
  • The characterization of hits and leads by a broad spectrum of assay technologies
  • Sophisticated medicinal chemistry and analytics for hit and lead optimization
  • Project management of discovery and preclinical R&D
Collaborative R&D. From hit to clinical candidate.